Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for hyperactivity and attention difficulties in children and grown-ups . In Canada, its availability is overseen by Health Canada. https://apo-lisdexamfetamine-in-579083.blog-center.com/61715386/this-medication-in-canada-a-detailed-guide